A landmark study in the fight against prostate cancer is producing promising results. Scientists at Washington University and Siteman Cancer Center are conducting the research which is giving new hope to patients diagnosed with the deadly disease. “Two years ago, I was diagnosed with prostate cancer,” said 67-year-old Bill Petersen, a loving husband, father, and grandfather. “I had no symptoms at all.”
After completing chemotherapy treatments Petersen became the first patient to enroll in a prostate cancer antigen vaccine trial. “He’s been doing great so far,” said Dr. Russell Pachynski, a renowned oncologist at Siteman Cancer Center.
To read the full article: https://bit.ly/304aKS8